A proper balance between bone formation (new bone development) and bone turnover (replacing old bone) is missing in patients with diabetes. A new compound, referenced as "SR10171", was developed at the Scripps Research Institute (TSRI) and the new drug can be used for the treatment of bone disease and diabetes.
The authors of the study are Prof. Patrick R. Griffin (The Scripps Research Institute, TSRI) and Prof. B Lecka-Czernik (University of Toledo). The study was published in the Journal EBioMedicine.
A study led by Dr. Timothy Davis, the University of Western Australia has analyzed the effects of eGFR on 1,296 people with type 2 diabetes (T2D).
A rapid decline in the renal function with a high eGFR can increase the risk of death in patients with type 2 diabetes (T2D).
The study was published in the European Journal of Endocrinology.
The researchers have examined about 4,000 genetically identical twins derived from a single ovum to evaluate the risk associated with genetic factors and obesity.
The study shows that weight loss can lower the risk of diabetes. The health benefits of weight loss are more to diabetes when compared with cardiovascular disease (CVD) or mortality.
The study was published online in the JAMA Internal Medicine.
An earlier study has indicated that diabetes can increase the risk of age-related cognitive declines, such as memory and thinking skills.
A retrospective observational study by Dr. Anand Vaidya, MD, the Harvard Medical School, Boston has indicated a 2-fold increased risk of diabetes or prediabetes in patients with the non-functional adrenal tumors (NFATs).
The study shows that the non-functional adrenal tumors (NFATs) may secrete excess glucocorticoids, which may increase the risk of metabolic diseases and diabetes.
The study was published in the journal Annals Of Internal Medicine. The study was funded by the National Institutes of Health and the Doris Duke Charitable Foundation.
A study by lead researcher Dr. Michael Holmes, from Oxford University shows that statin pills can decrease the bad cholesterol from our body but can increase the risk of diabetes.
To avoid diabetes, a patient using statin pills should increase the levels of high-density lipoprotein (LDL) cholesterol.
But the guidelines for both the diseases may not change as the benefits of statin pills are more. The study was published in the journal JAMA Cardiology.
The researchers have analyzed the following five important factors (called metabolic syndrome) that may increase the risk of heart disease in women.
The researchers say that the above five factors (called metabolic syndrome) can increase the risk of diabetes and heart diseases. The study was published on Aug 3, 2016, in the Journal of the American Heart Association.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.